References
- Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE. 2000. The protein data bank. Nucleic Acids Res. 28:235–242.
- Butler MS, Buss AD. 2006. Natural products – the future scaffolds for novel antibiotics? Biochem Pharmacol. 71:919–929.
- Dhanda SK, Singla D, Mondal AK, Raghava GP. 2013. DrugMint: a webserver for predicting and designing of drug-like molecules. Biol Direct. 8:28.
- DeLano WL. 2002. The PyMOL molecular graphics system. San Carlos, CA: DeLano Scientific.
- Demain AL. 2009. Antibiotics: natural products essential to human health. Med Res Rev. 29:821–842.
- Irwin JJ, Shoichet BK. 2005. ZINC – a free database of commercially available compounds for virtual screening. J Chem Inf Model. 45:177–182.
- King AM, Reid-Yu SA, Wang W, King DT, de Pascale G, Strynadka NC, Walsh TR, Coombes BK, Wright GD. 2014. Aspergillomarasmine A overcomes metallo-β-lactamase antibiotic resistance. Nature. 510:503–506.
- Labute P. 2009. Protonate3D: assignment of ionization states and hydrogen coordinates to macromolecular structures. Proteins. 75:187–205.
- Magiorakos AP, Srinivasan A, Carey RB. 2012. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 18:268–281.
- Meng EC, Shoichet BK, Kuntz ID. 1992. Automated docking with grid-based energy evaluation. J Comput Chem. 13:505–524.
- Nikaido H. 2009. Multidrug resistance in bacteria. Ann Rev Biochem. 78:119–146.
- Ponder JW, Richards FM. 1987. An efficient Newton-like method for molecular mechanics energy minimization of large molecules. J Comput Chem. 8:1016–1024.
- Saleem M, Nazir M, Ali MS, Hussain H, Lee YS, Riaz N, Jabbar A. 2010. Antimicrobial natural products: an update on future antibiotic drug candidates. Nat Prod Rep. 27:238–254.
- Volkamer A, Kuhn D, Rippmann F, Rarey M. 2012. DoGSiteScorer: a web server for automatic binding site prediction, analysis and druggability assessment. Bioinformatics. 28:2074–2075.
- Vriend G. 1990. WHAT IF: a molecular modelling and drug design program. J Mol Graph. 8:52–56.
- Zhou P, Huang J, Tian F. 2012. Specific noncovalent interactions at protein-ligand interface: implications for rational drug design. Curr Med Chem. 19:226–238.
- Zhou P, Wang C, Ren Y, Yang C, Tian F. 2013. Computational peptidology: a new and promising approach to therapeutic peptide design. Curr Med Chem. 20:1985–1996.